Picture

Review of the year 2023 on women’s health

It’s been an exciting year for women’s health and FDA’s Office of Women’s Health (OWH) is proud to continue its important work supporting FDA’s regulatory mission and protecting and promoting women’s health through policy, science, education and awareness.

As we approach the end of the year, we’re recapping some of the work we’ve done this year to advance women’s health. In 2023 alone, our office distributed more than 1.6 million women’s health publications to inform, empower and engage our diverse stakeholders.

We encourage you to take the time to read and share our free resources with your communities, organizations and healthcare offices. Below are some highlights from OWH this year.

OWH Webinars, Workshops and Scientific Meetings

Throughout the year, OWH hosted educational webinars for FDA and HHS employees, as well as public workshops and webinars for healthcare professionals and other stakeholders on the latest scientific research on a wide range of health topics important to women.

Public workshops and meetings included: PCOS revisited: diagnosis, management and future needs, Menopause: potential impact on clinical pharmacology and opportunities for future research and bringing clinical research to patients. Learn more and view recordings of these and other OWH events.

OWH Funding Initiatives and Research Publications

OVH price Research grant for studies addressing regulatory research questions related to women’s health issues and the impact of gender differences on product safety and effectiveness. In 2023, we funded a wide variety of projects under OWH Women’s Health Research Program, such as a study on human skin models to predict the absorption of cosmetic ingredients, a project evaluating gender disparities in opioid drug safety signals, and a project with a systematic approach to predict excretion of antidepressants in breast milk. OWH research funded in previous years has produced several peer-reviewed publications in 2023, on topics including heart failure, machine learning algorithms, medical device validation, and SARS-CoV-2 ( the virus that causes COVID-19).

OWH staff also published peer-reviewed scientific articles on topics such as the use of medications during pregnancy, the use of hormone replacement therapy (HRT) to treat menopausal symptoms, and the participation of treatment-naïve HIV-1-infected women in clinical trials and gender differences in effectiveness and safety.

Consumer awareness and education resources

OWH Theme for National Women’s Health Week (NWHW) 2023 should encourage women to #KNOW more about your health, today and every day. Some of the topics highlighted during the week included pregnancy, uterine fibroids, menopause and polycystic ovarian syndrome (PCOS).

In 2023, OWH produced a new video And Blog to provide information about pregnancy exposure records. Pregnancy exposure registries are research studies that collect information about the effects of prescription drugs taken or vaccines received during pregnancy. We encourage you to learn more and review our updated pregnancy exposure records. web pages.

A few years ago, OWH created the Blog Knowledge and news on women’s health to educate and share the latest topics and ideas on women’s health that may not be well known to women and other stakeholders. In addition to the OWH Pregnancy Registry Blog, additional topics have been included women and heart health, PCOS, minority mental healthAnd mammography.

Our researchers are carrying out important and groundbreaking work in science, technology, engineering and mathematics (STEM) through the FDA. In honour of National STEM Day, OWH members spoke about what it means to pursue a career in STEM and why we need more young women in this industry. Check out our video and FDA STEM Day Web page to learn more.

Raise awareness of the importance of mammograms for breast cancer screening, OWH has developed new resources on mammography, including a new video, BlogAnd social media toolkit (PDF, 1.8 MB) and updated mammography web page to help educate women about the importance of mammograms as the best primary screening tool for detecting breast cancer.

In 2023, OWH has distributed more than 1.6 million publications on women’s health to inform, empower and involve our various stakeholders. OWH has created a new women and anxiety Web content and fact sheets in 19 languages ​​to provide women with more information about anxiety symptoms, common treatment options, and more. OWH updated the heart health social media toolkit (PDF, 6.67 MB) to help women learn more about heart disease. Visit our heart health Web page to learn more.

We have also updated our University Women’s Campaign (CWC) to help students and schools share our free women’s health resources on campus and in communities. Check out the update CIAC webpagedownload the toolkit in English (PDF, 13.84 MB) and Spanish (PDF, 602 KB), and order the new revised 5 Steps to Safe Medication Use for Female Students (PDF, 6.7 MB) poster to be displayed on university campuses.

We encourage you to review and share this and other OWH information. topic of women’s health resources and share this blog with a friend or colleague.

For resources and materials on other women’s health topics, visit www.fda.gov/womens.